Anticoagulant Injections Market, Global Outlook and Forecast 2022-2028

May 2022 | 65 pages | ID: A8405E294EE3EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Anticoagulant Injections in Global, including the following market information:

Global Anticoagulant Injections Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Anticoagulant Injections market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

LMWH Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anticoagulant Injections include Sanofi, Genentech (Roche), Boehringer Ingelheim, Aspen, Pfizer, Hepalink, King-friend, CSBIO and Amphastar Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulant Injections companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anticoagulant Injections Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Anticoagulant Injections Market Segment Percentages, by Type, 2021 (%)

• LMWH
• Unfractionated Heparin
• Fibrinolytics
• Other

Global Anticoagulant Injections Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Anticoagulant Injections Market Segment Percentages, by Application, 2021 (%)

• VTE
• ACS/MI
• AF
• Other

Global Anticoagulant Injections Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Anticoagulant Injections Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anticoagulant Injections revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Anticoagulant Injections revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Aspen
• Pfizer
• Hepalink
• King-friend
• CSBIO
• Amphastar Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anticoagulant Injections Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anticoagulant Injections Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTICOAGULANT INJECTIONS OVERALL MARKET SIZE

2.1 Global Anticoagulant Injections Market Size: 2021 VS 2028
2.2 Global Anticoagulant Injections Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Anticoagulant Injections Players in Global Market
3.2 Top Global Anticoagulant Injections Companies Ranked by Revenue
3.3 Global Anticoagulant Injections Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulant Injections Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anticoagulant Injections Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulant Injections Players in Global Market
  3.6.1 List of Global Tier 1 Anticoagulant Injections Companies
  3.6.2 List of Global Tier 2 and Tier 3 Anticoagulant Injections Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Anticoagulant Injections Market Size Markets, 2021 & 2028
  4.1.2 LMWH
  4.1.3 Unfractionated Heparin
  4.1.4 Fibrinolytics
  4.1.5 Other
4.2 By Type - Global Anticoagulant Injections Revenue & Forecasts
  4.2.1 By Type - Global Anticoagulant Injections Revenue, 2017-2022
  4.2.2 By Type - Global Anticoagulant Injections Revenue, 2023-2028
  4.2.3 By Type - Global Anticoagulant Injections Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anticoagulant Injections Market Size, 2021 & 2028
  5.1.2 VTE
  5.1.3 ACS/MI
  5.1.4 AF
  5.1.5 Other
5.2 By Application - Global Anticoagulant Injections Revenue & Forecasts
  5.2.1 By Application - Global Anticoagulant Injections Revenue, 2017-2022
  5.2.2 By Application - Global Anticoagulant Injections Revenue, 2023-2028
  5.2.3 By Application - Global Anticoagulant Injections Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anticoagulant Injections Market Size, 2021 & 2028
6.2 By Region - Global Anticoagulant Injections Revenue & Forecasts
  6.2.1 By Region - Global Anticoagulant Injections Revenue, 2017-2022
  6.2.2 By Region - Global Anticoagulant Injections Revenue, 2023-2028
  6.2.3 By Region - Global Anticoagulant Injections Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Anticoagulant Injections Revenue, 2017-2028
  6.3.2 US Anticoagulant Injections Market Size, 2017-2028
  6.3.3 Canada Anticoagulant Injections Market Size, 2017-2028
  6.3.4 Mexico Anticoagulant Injections Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Anticoagulant Injections Revenue, 2017-2028
  6.4.2 Germany Anticoagulant Injections Market Size, 2017-2028
  6.4.3 France Anticoagulant Injections Market Size, 2017-2028
  6.4.4 U.K. Anticoagulant Injections Market Size, 2017-2028
  6.4.5 Italy Anticoagulant Injections Market Size, 2017-2028
  6.4.6 Russia Anticoagulant Injections Market Size, 2017-2028
  6.4.7 Nordic Countries Anticoagulant Injections Market Size, 2017-2028
  6.4.8 Benelux Anticoagulant Injections Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Anticoagulant Injections Revenue, 2017-2028
  6.5.2 China Anticoagulant Injections Market Size, 2017-2028
  6.5.3 Japan Anticoagulant Injections Market Size, 2017-2028
  6.5.4 South Korea Anticoagulant Injections Market Size, 2017-2028
  6.5.5 Southeast Asia Anticoagulant Injections Market Size, 2017-2028
  6.5.6 India Anticoagulant Injections Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Anticoagulant Injections Revenue, 2017-2028
  6.6.2 Brazil Anticoagulant Injections Market Size, 2017-2028
  6.6.3 Argentina Anticoagulant Injections Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Anticoagulant Injections Revenue, 2017-2028
  6.7.2 Turkey Anticoagulant Injections Market Size, 2017-2028
  6.7.3 Israel Anticoagulant Injections Market Size, 2017-2028
  6.7.4 Saudi Arabia Anticoagulant Injections Market Size, 2017-2028
  6.7.5 UAE Anticoagulant Injections Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Anticoagulant Injections Major Product Offerings
  7.1.4 Sanofi Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Genentech (Roche)
  7.2.1 Genentech (Roche) Corporate Summary
  7.2.2 Genentech (Roche) Business Overview
  7.2.3 Genentech (Roche) Anticoagulant Injections Major Product Offerings
  7.2.4 Genentech (Roche) Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.2.5 Genentech (Roche) Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Anticoagulant Injections Major Product Offerings
  7.3.4 Boehringer Ingelheim Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Aspen
  7.4.1 Aspen Corporate Summary
  7.4.2 Aspen Business Overview
  7.4.3 Aspen Anticoagulant Injections Major Product Offerings
  7.4.4 Aspen Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.4.5 Aspen Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Anticoagulant Injections Major Product Offerings
  7.5.4 Pfizer Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Hepalink
  7.6.1 Hepalink Corporate Summary
  7.6.2 Hepalink Business Overview
  7.6.3 Hepalink Anticoagulant Injections Major Product Offerings
  7.6.4 Hepalink Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.6.5 Hepalink Key News
7.7 King-friend
  7.7.1 King-friend Corporate Summary
  7.7.2 King-friend Business Overview
  7.7.3 King-friend Anticoagulant Injections Major Product Offerings
  7.7.4 King-friend Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.7.5 King-friend Key News
7.8 CSBIO
  7.8.1 CSBIO Corporate Summary
  7.8.2 CSBIO Business Overview
  7.8.3 CSBIO Anticoagulant Injections Major Product Offerings
  7.8.4 CSBIO Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.8.5 CSBIO Key News
7.9 Amphastar Pharmaceuticals
  7.9.1 Amphastar Pharmaceuticals Corporate Summary
  7.9.2 Amphastar Pharmaceuticals Business Overview
  7.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Major Product Offerings
  7.9.4 Amphastar Pharmaceuticals Anticoagulant Injections Revenue in Global Market (2017-2022)
  7.9.5 Amphastar Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Anticoagulant Injections Market Opportunities & Trends in Global Market
Table 2. Anticoagulant Injections Market Drivers in Global Market
Table 3. Anticoagulant Injections Market Restraints in Global Market
Table 4. Key Players of Anticoagulant Injections in Global Market
Table 5. Top Anticoagulant Injections Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anticoagulant Injections Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anticoagulant Injections Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anticoagulant Injections Product Type
Table 9. List of Global Tier 1 Anticoagulant Injections Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticoagulant Injections Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anticoagulant Injections Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anticoagulant Injections Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anticoagulant Injections Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anticoagulant Injections Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anticoagulant Injections Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anticoagulant Injections Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anticoagulant Injections Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anticoagulant Injections Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anticoagulant Injections Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anticoagulant Injections Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anticoagulant Injections Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anticoagulant Injections Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anticoagulant Injections Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anticoagulant Injections Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anticoagulant Injections Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anticoagulant Injections Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anticoagulant Injections Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anticoagulant Injections Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anticoagulant Injections Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Anticoagulant Injections Product Offerings
Table 32. Sanofi Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 33. Genentech (Roche) Corporate Summary
Table 34. Genentech (Roche) Anticoagulant Injections Product Offerings
Table 35. Genentech (Roche) Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Anticoagulant Injections Product Offerings
Table 38. Boehringer Ingelheim Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 39. Aspen Corporate Summary
Table 40. Aspen Anticoagulant Injections Product Offerings
Table 41. Aspen Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Anticoagulant Injections Product Offerings
Table 44. Pfizer Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 45. Hepalink Corporate Summary
Table 46. Hepalink Anticoagulant Injections Product Offerings
Table 47. Hepalink Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 48. King-friend Corporate Summary
Table 49. King-friend Anticoagulant Injections Product Offerings
Table 50. King-friend Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 51. CSBIO Corporate Summary
Table 52. CSBIO Anticoagulant Injections Product Offerings
Table 53. CSBIO Anticoagulant Injections Revenue (US$, Mn), (2017-2022)
Table 54. Amphastar Pharmaceuticals Corporate Summary
Table 55. Amphastar Pharmaceuticals Anticoagulant Injections Product Offerings
Table 56. Amphastar Pharmaceuticals Anticoagulant Injections Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Anticoagulant Injections Segment by Type in 2021
Figure 2. Anticoagulant Injections Segment by Application in 2021
Figure 3. Global Anticoagulant Injections Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anticoagulant Injections Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anticoagulant Injections Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticoagulant Injections Revenue in 2021
Figure 8. By Type - Global Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 12. US Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 16. Germany Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 17. France Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 24. China Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 28. India Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 30. Brazil Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anticoagulant Injections Revenue Market Share, 2017-2028
Figure 33. Turkey Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anticoagulant Injections Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Genentech (Roche) Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aspen Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hepalink Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. King-friend Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. CSBIO Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amphastar Pharmaceuticals Anticoagulant Injections Revenue Year Over Year Growth (US$, Mn) & (2017-2022)